Figure 3. . Relative efficacy and SUCRA of the endoscopic healing rates at (A & B) 4 and (C & D) 8 weeks.
PPI: Proton pump inhibitors; VPZ5: Vonoprazan 5 mg; VPZ10: Vonoprazan 10 mg; VPZ20: Vonoprazan 20 mg; VPZ40: Vonoprazan 40 mg; TEAEs: Treatment-emergent adverse events; SUCRA: Surface under the cumulative ranking.
